CARRIER GLOBAL CORPORATION (CARR) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.81%; Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 0.33%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.81% | Research and development expense / revenue. Period ending 2026-03-31. $615.00M ÷ $21.87B × 100 ≈ 2.81% |
| Stock-based compensation / revenue · 12 months | 0.33% | Share-based compensation / revenue. Period ending 2026-03-31. $72.00M ÷ $21.87B × 100 ≈ 0.33% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 615.00M USD | Research and Development Expense |
| Revenue | 21.87B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 72.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.80B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $615.00M | $21.87B | $72.00M | $1.80B | (m) | 2.81% | 0.33% | (m) | (m) |
| 2025-12-31 | $625.00M | $21.75B | $74.00M | $2.17B | (m) | 2.87% | 0.34% | (m) | (m) |
| 2025-09-30 | $627.00M | $22.06B | $77.00M | $2.85B | (m) | 2.84% | 0.35% | (m) | (m) |
| 2025-06-30 | $648.00M | $22.46B | $94.00M | $3.07B | (m) | 2.88% | 0.42% | (m) | (m) |
| 2025-03-31 | $647.00M | $22.28B | $99.00M | $2.89B | (m) | 2.90% | 0.44% | (m) | (m) |
| 2024-12-31 | $686.00M | $22.49B | $98.00M | $2.65B | (m) | 3.05% | 0.44% | (m) | (m) |
| 2024-09-30 | $786.00M | $24.80B | $94.00M | $2.55B | (m) | 3.17% | 0.38% | (m) | (m) |
| 2024-06-30 | $738.00M | $23.70B | $89.00M | $5.44B | (m) | 3.11% | 0.38% | (m) | (m) |
| 2024-03-31 | $702.00M | $23.01B | $81.00M | $2.24B | (m) | 3.05% | 0.35% | (m) | (m) |
| 2023-12-31 | $617.00M | $22.10B | $81.00M | $2.30B | (m) | 2.79% | 0.37% | (m) | (m) |
| 2023-09-30 | $596.00M | $22.10B | $82.00M | $2.12B | (m) | 2.70% | 0.37% | (m) | (m) |
| 2023-06-30 | $582.00M | $21.82B | $76.00M | $3.00B | (m) | 2.67% | 0.35% | (m) | (m) |
| 2023-03-31 | $553.00M | $21.04B | $78.00M | $3.33B | (m) | 2.63% | 0.37% | (m) | (m) |
| 2022-12-31 | $539.00M | $20.42B | $77.00M | $4.51B | (m) | 2.64% | 0.38% | (m) | (m) |
| 2022-09-30 | $524.00M | $20.45B | $90.00M | $4.54B | (m) | 2.56% | 0.44% | (m) | (m) |
| 2022-06-30 | $504.00M | $20.34B | $93.00M | $3.85B | (m) | 2.48% | 0.46% | (m) | (m) |
| 2022-03-31 | $507.00M | $20.57B | $94.00M | $3.81B | (m) | 2.46% | 0.46% | (m) | (m) |
| 2021-12-31 | $503.00M | $20.61B | $92.00M | $2.65B | (m) | 2.44% | 0.45% | (m) | (m) |
| 2021-09-30 | $496.00M | $20.07B | $81.00M | $3.43B | (m) | 2.47% | 0.40% | (m) | (m) |
| 2021-06-30 | $473.00M | $19.73B | $82.00M | $3.68B | (m) | 2.40% | 0.42% | (m) | (m) |
| 2021-03-31 | $442.00M | $18.27B | $83.00M | $3.34B | (m) | 2.42% | 0.45% | (m) | (m) |
| 2020-12-31 | $419.00M | $17.46B | $77.00M | $3.08B | (m) | 2.40% | 0.44% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $401.00M | $18.61B | $52.00M | $2.49B | (m) | 2.15% | 0.28% | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $400.00M | $18.91B | $44.00M | $3.64B | (m) | 2.11% | 0.23% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENNOX INTERNATIONAL INC (LII) | United States | $12.800B | 20.13 |
| AAON, INC. (AAON) | United States | $6.951B | 65.66 |
| Johnson Controls International plc (JCI) | $88.680B | 22.62 | |
| AirJoule Technologies Corp. (AIRJ) | United States | $0.298B | -4.47 |
| TECOGEN INC. (TGEN) | United States | $0.091B | -15.11 |